
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Alpha-Tocopheryloxyacetic Acid,Trastuzumab
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : University of Washington
Deal Size : Inapplicable
Deal Type : Inapplicable
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer
Details : Alpha-Tocopheryloxyacetic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Breast Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 09, 2019
Lead Product(s) : Alpha-Tocopheryloxyacetic Acid,Trastuzumab
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : University of Washington
Deal Size : Inapplicable
Deal Type : Inapplicable
